NCX1/Ca2+ promotes autophagy and decreases bortezomib activity in multiple myeloma through non-canonical NF κB signaling pathway

Although bortezomib (BTZ) is the cornerstone of anti-multiple myeloma (MM) therapy, the inevitable primary and secondary drug resistance still seriously affects the prognosis of patients. New treatment strateg...

Source: Cell Communication and Signaling - May 6, 2024 Category: Molecular Biology Authors: Tingting Li, Pingping Xiao, Dongbiao Qiu, Apeng Yang, Qingjiao Chen, Junfang Lin, Yao Liu, Junmin Chen and Zhiyong Zeng Tags: Research Source Type: research